Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Direct coupling at phosphorus
What ifWhat if a pentavalent phosphorus reagent forms a phosphorothioate linkage directly?
A protected nucleoside carrying an activated phosphorus(V) thiophosphoryl group reacts with an exposed hydroxyl on the growing chain. Displacement of the leaving group forms the internucleoside bond while phosphorus stays in the +5 oxidation state.
1.1Amide formation by acyl transfer
What ifWhat if an activated carboxyl group and an amine form the modified linkage by acyl transfer?
Claim language“an oxidizing solution”
One protected oligonucleotide segment carries a terminal carboxyl group, and the other carries a terminal primary amine. Conversion of the carboxyl group to an activated ester allows the amine to form an amide bridge between the segments.
1.2A carbocyclic aryl substituent
What ifWhat if a phenyl group attaches directly to a phosphorus center in the internucleoside bridge?
Claim language“optionally substituted heteroaryl”
An activated phenylphosphonyl group on a protected nucleoside supplies a preformed phosphorus–carbon bond. Coupling to the exposed hydroxyl of a second nucleoside forms a phenylphosphonate bridge with two phosphorus–oxygen bonds to the nucleosides.
1.3A cyclic amino group
What ifWhat if a phosphorus-bound amino substituent comes from piperidine, with the two carbon chains on nitrogen joined into a ring?
Claim language“selected from C1-C12 alkyl”
Piperidine displaces a leaving group on an activated pentavalent phosphorus precursor to form a phosphorus–nitrogen bond. A remaining reactive group at phosphorus couples with a nucleoside hydroxyl to form a phosphoramidate linkage bearing the piperidine ring.
1.4Flow through a fixed bed
What ifWhat if reagent solutions pass through a stationary packed column?
Claim language“a stirred bed reactor”
Porous support particles sit between two frits and carry the growing oligonucleotide chains. A pump delivers successive reagent and wash solutions through the particle bed, and valves set the contact time for each step.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Stirred bed preparation of chromatography references
A stirred bed reactor prepares a dinucleotide reference for analytical chromatography. The two nucleosides are initially joined by a phosphite triester on an insoluble support, and the oxidation step converts that single linkage to a modified linkage. After release from the support, the purified dinucleotide serves as a retention reference in assays for short synthesis byproducts.
Component substitution
Fluoropolymer impeller for bead suspension
A polytetrafluoroethylene paddle replaces the glass impeller in a stirred bed reactor used to prepare a dinucleotide reference. The paddle mounts on a top-entry shaft above the screened drain, with clearance from the vessel wall and bottom. The drive rotates the paddle to suspend the beads during liquid contact and stops before the liquid drains through the screen.
Parameter or scale variation
Two vessel sizes for mixing checks
Two geometrically similar stirred vessels have nominal volumes of 50 mL and 500 mL and liquid fills of 25 mL and 250 mL, respectively. Each vessel uses inert beads at the same solids volume fraction and a paddle one-third of the vessel diameter. A soluble dye pulse and video of the vessel bottom provide separate measurements of liquid mixing time and the presence of settled beads.
Combination with existing systems
Chromatography coupled to a stirred reactor
A stirred bed reactor for dinucleotide reference preparation connects to a liquid chromatography system through a screened sampling port and a collection vial. The port retains the synthesis beads and routes a small portion of the drain stream into the vial. The chromatography system analyzes the collected liquid for residual soluble reagent during washout.
Automated or data-driven variant
Gravimetric control of liquid transfers
A load cell beneath the reactor measures changes in vessel mass during filling and draining. Flexible tubing connects the vessel to the feed and drain valves and limits the forces transmitted to the weighing platform. The controller closes the feed valve at a preset mass increase and records each drain as complete when the measured mass stabilizes within a configured residual mass band.
Optical monitoring of bead suspension
A fixed camera views the lower portion of a transparent stirred vessel against a diffuse backlight during commissioning with inert beads. Software calculates the fraction of the bottom region occupied by stationary beads over successive frames. The system records that fraction alongside impeller speed and flags periods when the settled fraction exceeds a preset threshold.
Specific version of a part
A five membered heteroaryl group
R is thiophen-2-yl, a five-membered aromatic ring containing sulfur. Carbon 2, adjacent to sulfur, forms the attachment point to the rest of the linking group.
Methyl as the sulfonyl substituent
R3 is methyl, giving the group –SO₂CH₃. The methyl carbon bonds directly to the sulfonyl sulfur.
Two ethyl groups on nitrogen
R4 and R5 are both ethyl. Each nitrogen in –(NR4R5)₂ carries two ethyl substituents through nitrogen–carbon bonds.
An impeller stirred support bed
A pitched-blade impeller circulates reagent solution through a swollen polymer support bearing the growing oligonucleotide. A frit at the vessel outlet retains the support particles while the spent solution drains and fresh wash solvent enters.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1contacting an oligonucleotide intermediate having a phosphite triester internucleoside linkage with an oxidizing solution comprising a oxidizing agent to form an oligonucleotide having an internucleoside linking group of formula I
What makes the situation even more complicated is that during oligonucleotide synthesis, one of the steps in each of the many synthetic cycles is oxidation of a phosphite triester to a phosphate triester.
A · US 2023/0203084 A1 · ¶ 188
A process for the production of a mixed P═O/P═S backbone oligonucleotide comprising the oxidation of an intermediary phosphite triester compound of formula I into a phosphodiester compound of formula II according to the scheme with an oxidation solution obtained by mixing iodine, an organic solvent and water, characterized in that the oxidation solution has been aged for a time period that is sufficient to selectively oxidize the phosphite triester compound of formula I into
B · US 2023/0295207 A1 · claim 1
1.2wherein R is selected from —SO2R3, —(NR4R5)2, optionally substituted heterocycloalkyl, optionally substituted heteroaryl
1.3wherein R3 is selected from optionally substitute aryl, optionally substituted heterocycloalkyl, optionally substituted heteroaryl, C1-C6 alkoxy, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, R4 and R5 are independently selected from C1-C12 alkyl
1.4wherein the method is performed in a stirred bed reactor.
An empty cell means only that no passage was reproduced there.
Statements in these documents
However, using existing oligonucleotide synthesis technologies, almost all these groups, which we call sensitive groups, cannot be incorporated into oligonucleotides.
A · US 2023/0203084 A1 · ¶ 3
Oligonucleotides containing one or more sensitive groups, if they could be synthesized, would find numerous applications in many areas including molecular biology, biomedical research, medicine, and nanotechnology.
A · US 2023/0203084 A1 · ¶ 4
The invention relates to a novel process for the production of a mixed P═O/P═S backbone oligonucleotide comprising the oxidation of an intermediary phosphite triester compound of formula I into a phosphodiester compound of formula II according to the scheme
B · US 2023/0295207 A1 · ¶ 3
Cite aspatent.fyi, US 2026/0356877 A1, claim 1, first published 2026-11-20T08:11:50-05:00, https://patent.fyi/US20260356877/, SHA-256 2bf693587fa924a09e0cc656d12710de0097da282733f82e605ea79251d5cfe4